UR
BLUE

USCA RIA’s bluebird bio BLUE Stock Holding History

USCA RIA’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1.77M Sell
4,272
-142
-3% -$56.3K 0.11% 238
2021
Q1 		$1.72M Buy
4,414
+1,537
+53% +$757K 0.11% 235
2020
Q4 		$1.61M Sell
2,877
-364
-11% -$231K 0.11% 176
2020
Q3 		$2.27M Buy
3,241
+632
+24% +$493K 0.18% 120
2020
Q2 		$2.06M Buy
2,609
+809
+45% +$610K 0.18% 120
2020
Q1 		$1.07M Buy
1,800
+261
+17% +$254K 0.12% 179
2019
Q4 		$1.75M Buy
1,539
+499
+48% +$542K 0.16% 183
2019
Q3 		$1.24M Buy
1,040
+107
+11% +$163K 0.12% 208
2019
Q2 		$1.54M Buy
933
+71
+8% +$123K 0.16% 174
2019
Q1 		$1.76M Buy
862
+12
+1% +$21.1K 0.19% 149
2018
Q4 		$1.09M Buy
850
+130
+18% +$199K 0.15% 174
2018
Q3 		$1.36M Buy
720
+102
+17% +$211K 0.14% 195
2018
Q2 		$1.26M Buy
618
+99
+19% +$226K 0.14% 194
2018
Q1 		$1.15M Buy
519
+49
+10% +$125K 0.13% 205
2017
Q4 		$1.08M Sell
470
-259
-36% -$526K 0.12% 194
2017
Q3 		$992K Hold
729
– – 0.13% 190
2017
Q2 		$992K Buy
729
+129
+22% +$156K 0.13% 191
2017
Q1 		$707K Buy
+600
New +$612K 0.1% 220

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

USCA RIA's BLUE Position: Q2 2021 in Review

USCA RIA reduced its bluebird bio (BLUE) stake by 3.2% in Q2 2021, selling an estimated $56.3K and leaving 4,272 shares worth $1.77M. The position accounts for 0.11% of the portfolio, ranked #238.

USCA RIA first reported a position in BLUE in Q1 2017 and has held it in 18 quarters since. The position peaked at $2.27M in Q3 2020. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • USCA RIA held 4,272 shares of bluebird bio worth $1.77M as of Q2 2021.
  • USCA RIA sold 142 bluebird bio shares in Q2 2021, an estimated $56.3K.
  • bluebird bio made up 0.11% of USCA RIA's portfolio in Q2 2021, its #238 holding.
  • USCA RIA first reported a position in bluebird bio in Q1 2017 and has held it in 18 quarters since.
  • USCA RIA's bluebird bio position peaked at $2.27M in Q3 2020.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.